Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $154.28 billion as of January 7, 2026. Its market cap has increased by 36.50% in one year.

Market Cap

154.28B

Enterprise Value

167.24B

1-Year Change

36.50%

Ranking

#98

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $154.28B, an increase of 15,754.33%. That is a compound annual growth rate of 20.54%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	150.57B	-1.12%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	984.30B
Johnson & Johnson	498.07B
AbbVie	402.52B
UnitedHealth Group	308.94B
AstraZeneca	293.89B
Merck & Co.	269.40B
Novartis AG	268.87B
Novo Nordisk	253.02B

Market Cap Rankings